Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams
NCT00800293 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 116
Last updated 2021-10-18
Summary
The purpose of this study was to compare the relative vasoconstrictive effects of test and reference topical augmented betamethasone dipropionate augmented 0.05% cream in healthy, female subjects.
Conditions
- Healthy
Interventions
- DRUG
-
Betamethasone Dipropionate 0.05% Cream
Small amount applied and evaluated over the course of several hours
Sponsors & Collaborators
-
Padagis LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2002-12-31
- Primary Completion
- 2003-01-31
- Completion
- 2003-01-31
More Related Trials
-
Efficacy of Gynodian® Depot in Women With Impaired Well-being
NCT00463450 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis
NCT02195986 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Equivalence of Estradiol Vaginal Cream 0.01% to Estrace® Cream 0.01% in Atrophic Vaginitis
NCT03294538 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Bazedoxifene/Conjugated Estrogen Combinations in Symptoms Associated With Menopause
NCT00234819 ·Status: COMPLETED ·Phase: PHASE3
-
Vaginal Testosterone Cream For Atrophic Vaginitis in Women Taking Aromatase Inhibitors for Breast Cancer.
NCT01122342 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2
-
A Pharmacokinetic Evaluation of Bioidentical Compounded Estrogen Cream and Natural Progesterone
NCT00864214 ·Status: COMPLETED ·Phase: PHASE1
-
A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women
NCT01634789 ·Status: TERMINATED ·Phase: PHASE1
-
Bioequivalence of Testosterone Reduced-size Patch Relative to the Testosterone Reference Patch
NCT00791856 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating The Effects Of Bazedoxifene/Conjugated Estrogens On Endometrial Safety And Postmenopausal Osteoporosis
NCT00808132 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Estradiol Topical Products
NCT05645393 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A New Hormone Replacement Paradigm: Physiologic Restoration Study
NCT04190927 ·Status: UNKNOWN ·Phase: PHASE4
-
Buccal Estrogen in Toothpaste Study: Systemic Absorption of Estradiol When Administered Mixed With Toothpaste in Postmenopausal or Surgically Menopausal Women
NCT00029757 ·Status: COMPLETED ·Phase: NA
-
Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers
NCT00236301 ·Status: TERMINATED ·Phase: PHASE3
-
Multicenter Study to Evaluate Safety and Efficacy of WC3011 (Estradiol Vaginal Cream) in Postmenopausal Women
NCT01816139 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating Safety and Efficacy of Bazedoxifene/Conjugated Estrogens Combinations in Postmenopausal Women
NCT00675688 ·Status: COMPLETED ·Phase: PHASE3
-
Sex Hormones and Atherosclerosis Prevention in Perimenopausal Women
NCT00608062 ·Status: COMPLETED ·Phase: NA
-
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
NCT00026286 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms
NCT00391417 ·Status: COMPLETED ·Phase: PHASE3
-
Relieving Vasomotor Symptoms Effectively With Bioidentical Hormone Replacement Therapy: The REVERT Study
NCT01862861 ·Status: COMPLETED
-
Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women
NCT00396799 ·Status: COMPLETED ·Phase: PHASE1
-
Study Evaluating Bazedoxifene/Conjugated Estrogens Combinations In Healthy Postmenopausal Women
NCT00464789 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to Placebo
NCT01779947 ·Status: COMPLETED ·Phase: PHASE3
-
Low-dose Hormone Therapy for Relief of Vasomotor Symptoms
NCT00446199 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label, MultiCenter Evaluation of the Use of Topically Administered FP1198 in Subjects With Pain Associated With Cyclic Mastalgia
NCT01105793 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Angeliq in Thai Women
NCT00185328 ·Status: COMPLETED ·Phase: PHASE4